Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, general and administrative | 98.4 | 142.4 | 102.4 | | |
| Research and development | | | | 47.0 | 34.2 |
| General and administrative | | | | 16.6 | 6.8 |
| EBIT | -78.8 | -137.7 | -89.9 | -63.6 | -41.0 |
| Pre-tax income | -88.6 | -140.0 | -96.2 | -53.8 | -33.3 |
| Income taxes | 0.4 | 0.3 | 0.1 | 0.1 | 0.0 |
| Net income | -89.0 | -140.4 | -96.3 | -53.9 | -33.3 |
| |
| Diluted EPS | ($1.50) | ($3.93) | ($6.81) | ($8.49) | ($7.20) |
| Shares outstanding (diluted) | 59.3 | 35.7 | 14.2 | 6.3 | 4.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|